Related Experiment Video

Updated: Jun 9, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Reframing pathologic staging in renal cell carcinoma after immunotherapy

Katrina Collins1, Steven Christopher Smith2

  • 1Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, United States.

American Journal of Clinical Pathology
|June 8, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
histopathologyimmune checkpoint inhibitorsimmunotherapyneoadjuvant therapypathologic stagingrenal cell carcinomatreatment effect

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.